ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07735
0,00%
Bitcoin
63.073,67
0,29%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NYSE
  6. Eli Lilly and Co (LLY)

  7. Eli Lilly and Co (LLY) News

LLY

Eli Lilly (LLY)

Eli Lilly and Co
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NYSE:LLY
DatumZeitQuelleÜberschriftSymbolFirma
30/04/202415h07IH Market NewsFutures Pointing To Roughly Flat Open On Wall StreetNYSE:LLYEli Lilly and Co
30/04/202413h59IH Market NewsU.S. Index Futures Point to Mild Decline Ahead of Key Earnings and Fed Rate DecisionNYSE:LLYEli Lilly and Co
30/04/202413h55IH Market NewsHSBC’s High Profit & CEO Resignation, Santander’s 11% Profit Surge, and More in EarningsNYSE:LLYEli Lilly and Co
30/04/202412h45PR Newswire (US)Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline MomentumNYSE:LLYEli Lilly and Co
17/04/202412h15PR Newswire (US)Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and obesityNYSE:LLYEli Lilly and Co
16/04/202416h00PR Newswire (US)Lilly Confirms Date and Conference Call for First-Quarter 2024 Financial Results AnnouncementNYSE:LLYEli Lilly and Co
03/04/202413h12IH Market NewsCal-Maine Surges on Strong Quarterly Performance, Taiwan Earthquake Disrupts Tech Supply Chain, and MoreNYSE:LLYEli Lilly and Co
11/03/202421h27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
11/03/202421h24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LLYEli Lilly and Co
10/03/202421h00PR Newswire (US)More than two-thirds of people with atopic dermatitis and skin of color experienced skin improvement in a first-of-its-kind lebrikizumab studyNYSE:LLYEli Lilly and Co
08/03/202412h45PR Newswire (US)U.S. Food and Drug Administration to Convene Advisory Committee Meeting to Discuss the TRAILBLAZER-ALZ 2 Study of DonanemabNYSE:LLYEli Lilly and Co
07/03/202414h00PR Newswire (US)Lilly's Newest Phase of Get Better Campaign Challenges Misperceptions About Obesity CareNYSE:LLYEli Lilly and Co
05/03/202423h00PR Newswire (US)Lilly Announces Details of Presentations at 2024 American Association for Cancer Research (AACR) Annual MeetingNYSE:LLYEli Lilly and Co
21/02/202422h26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
21/02/202422h24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
21/02/202422h21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
21/02/202422h18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
21/02/202422h16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
20/02/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
20/02/202416h00PR Newswire (US)Lilly to Participate in Cowen's 44th Annual Health Care ConferenceNYSE:LLYEli Lilly and Co
16/02/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
15/02/202421h05Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LLYEli Lilly and Co
14/02/202422h44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
14/02/202422h43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
14/02/202422h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
14/02/202422h39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
14/02/202422h38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
14/02/202422h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
14/02/202422h34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
14/02/202422h31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
 Showing the most relevant articles for your search:NYSE:LLY

Kürzlich von Ihnen besucht

FX
EURJPY
Euro vs Yen
COIN
SOLUSD
Solana
NASDAQ
NVDA
NVIDIA
NYSE
KO
Coca Cola
NASDAQ
MSFT
Microsoft
TG
D7G
Nel ASA
FX
EURGBP
Euro vs Sterling
TG
LHA
Deutsche Lufthansa
TG
NOV
Novo Nordisk
CCOM
SILVER
SILVER
TG
TUI1
Tui
NASDAQ
GOOGL
Alphabet
DBI
DAX
DAX
AMEX
XLF
Financial Select Sector
CCOM
US30
US 30
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten